Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

IGFBP7 antibody (Internal Region)

This Goat Polyclonal antibody specifically detects IGFBP7 in WB and EIA. It exhibits reactivity toward Human, Mouse and Rat.
Catalog No. ABIN498022

Quick Overview for IGFBP7 antibody (Internal Region) (ABIN498022)

Target

See all IGFBP7 Antibodies
IGFBP7 (Insulin-Like Growth Factor Binding Protein 7 (IGFBP7))

Reactivity

  • 64
  • 34
  • 26
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
Human, Mouse, Rat

Host

  • 63
  • 9
  • 2
  • 1
  • 1
Goat

Clonality

  • 59
  • 14
  • 2
Polyclonal

Conjugate

  • 41
  • 5
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
This IGFBP7 antibody is un-conjugated

Application

  • 50
  • 23
  • 23
  • 13
  • 13
  • 13
  • 13
  • 5
  • 4
  • 3
  • 3
  • 2
  • 2
  • 1
Western Blotting (WB), Enzyme Immunoassay (EIA)
  • Binding Specificity

    • 15
    • 7
    • 5
    • 4
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 145-159, Internal Region

    Sequence

    EKAITQVSKG TCEQG

    Specificity

    Recognizes IGFBP7 (145-159).

    Cross-Reactivity (Details)

    Species reactivity (expected):Human, Rat.
    Species reactivity (tested):Mouse.

    Purification

    Ammonium Sulphate Precipitation followed by Antigen Affinity Chromatography using the immunizing peptide.

    Immunogen

    Peptide with sequence from the internal region of the protein sequence according to NP_006423.1. Genename: IGFBP7
  • Application Notes

    Peptide ELISA: Limit Dilution: 1/8000. Western blot: 1-3 μg/mL. Approx 30 kDa band observed in Mouse Kidney lysates (calculatedMW of 29.0 kDa according to Human NP_001544.1 and to Mouse NP_032074.3).
    Other applications not tested.
    Optimal dilutions are dependent on conditions and should be determined by the user.

    Restrictions

    For Research Use only
  • Concentration

    0.5 mg/mL

    Buffer

    Tris saline, pH 7.3 containing 0.02 % Sodium Azide as preservative and 0.5 % BSA as stabilizer.

    Preservative

    Sodium azide

    Precaution of Use

    This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Handling Advice

    Avoid repeated freezing and thawing.

    Storage

    4 °C/-20 °C

    Storage Comment

    Store the antibody undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer.
  • Target

    IGFBP7 (Insulin-Like Growth Factor Binding Protein 7 (IGFBP7))

    Alternative Name

    IGFBP7

    Background

    IGF-BPs form high affinity complexes with both IGF-I and IGF-II and act to control of the distribution, function and activity of IGFs in various cell tissues and body fluids. There are seven named IGF-BPs. IGFBP7 plays a role in skeletal myogenesis by binding to IGF in a manner that inhibits IGF induced differentiation of skeletal myoblasts, without affecting IGF induced proliferation. Additionally, IGFBP7 suppresses growth and colony formation of prostate and breast cancer cell lines through an IGF independent mechanism, which causes a delay in the G1 phase of the cell cycle, and increased apoptosis. IGFBP7 is expressed in a wide range of normal human tissues and it usually shows reduced expression in cancer cell lines of prostate, breast, colon, and lung origin.Synonyms: IBP-7, IBP7, IGF-binding protein 7, IGFBP-7, IGFBP-rP1, Insulin-like growth factor-binding protein 7, MAC25, PGI2-stimulating factor, PSF, Prostacyclin-stimulating factor, TAF, Tumor-derived adhesion factor

    Gene ID

    3490

    NCBI Accession

    NP_001544

    UniProt

    Q16270

    Pathways

    Growth Factor Binding
You are here:
Chat with us!